Progesterone treatment in chylothorax associated with pulmonary tuberous sclerosis

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

We report the case of a young woman with tuberous sclerosis who developed a chylous pleural effusion after several invasive procedures for treatment of recurring pneumothoraces. Oophorectomy was rejected by the patient and progesterone therapy initiated. Medroxyprogesterone acetate administration led to a complete disappearance of the chylothorax in 8 months. The patient was kept on therapy, and no recurrence of pleural effusion has been observed up to the present (22 months follow-up). However, a progressive deterioration in pulmonary function was observed, with a significant decrease in pulmonary transfer factor and increase in airway obstruction. In conclusion, this report demonstrates an objective benefit of progesterone therapy on chylous effusion associated with pulmonary tuberous sclerosis.

Cite

CITATION STYLE

APA

Jounieaux, V., Druelle, S., Mayeux, I., Grimault, E., & Charet, J. C. (1996). Progesterone treatment in chylothorax associated with pulmonary tuberous sclerosis. European Respiratory Journal, 9(11), 2423–2425. https://doi.org/10.1183/09031936.96.09112423

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free